These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2603164)

  • 1. Correlation between behavioral and pathological changes in the evaluation of neurotoxicity.
    Broxup B; Robinson K; Losos G; Beyrouty P
    Toxicol Appl Pharmacol; 1989 Dec; 101(3):510-20. PubMed ID: 2603164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of dose rate on the neurotoxicity of acrylamide: the interaction of administered dose, target tissue concentrations, tissue damage, and functional effects.
    Crofton KM; Padilla S; Tilson HA; Anthony DC; Raymer JH; MacPhail RC
    Toxicol Appl Pharmacol; 1996 Jul; 139(1):163-76. PubMed ID: 8685900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the behavioral effects of neurotoxic and systemically toxic agents: how discriminatory are behavioral tests of neurotoxicity?
    Gerber GJ; O'Shaughnessy D
    Neurobehav Toxicol Teratol; 1986; 8(6):703-10. PubMed ID: 3543715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A correlative neurobehavioral-morphological model of acrylamide neuropathy.
    Sterman AB; Sheppard RC
    Neurobehav Toxicol Teratol; 1983; 5(1):151-9. PubMed ID: 6304547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the effects of acrylamide and 3,3'-iminopropionitrile (IDPN), using behavioral (functional observational battery and motor activity) and neuropathological end points.
    Crofton KM; Llorens J
    Fundam Appl Toxicol; 1992 Aug; 19(2):315-6. PubMed ID: 1516790
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the neurotoxicity of glycidamide, an epoxide metabolite of acrylamide: behavioral, neurochemical and morphological studies.
    Costa LG; Deng H; Calleman CJ; Bergmark E
    Toxicology; 1995 Apr; 98(1-3):151-61. PubMed ID: 7740544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurobehavioral toxicity of acrylamide and IDPN (3,3'-iminodipropionitrile) in rats by 28-day oral administration--problems encountered in collaborative study and a commentary on conducting neurobehavioral testing].
    Okazaki S; Takashima H; Yamaguchi M; Hamamura M; Yamashita K; Okada M; Sunaga M; Tanaka R; Sato S; Umano T; Tsuji R; Yosioka T; Fujii T
    J Toxicol Sci; 2003 May; 28 Suppl 1():1-14. PubMed ID: 12822443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxicity of acrylamide and 2,5-hexanedione in rats evaluated using a functional observational battery and pathological examination.
    Shell L; Rozum M; Jortner BS; Ehrich M
    Neurotoxicol Teratol; 1992; 14(4):273-83. PubMed ID: 1522832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behavioral syndrome caused by 3,3'-iminodipropionitrile and related nitriles in the rat is associated with degeneration of the vestibular sensory hair cells.
    Llorens J; Demêmes D; Sans A
    Toxicol Appl Pharmacol; 1993 Dec; 123(2):199-210. PubMed ID: 8248927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomic-cardiovascular dysfunction accompanies sensory-motor impairment during acrylamide intoxication.
    Sterman AB; Panasci DJ; Sheppard RC
    Neurotoxicology; 1983; 4(1):45-52. PubMed ID: 6683826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral effects of acrylamide in the mouse.
    Teal JJ; Evans HL
    Toxicol Appl Pharmacol; 1982 May; 63(3):470-80. PubMed ID: 7101304
    [No Abstract]   [Full Text] [Related]  

  • 12. Behavioral and pharmacological responses following acrylamide exposure in rats.
    Rafales LS; Bornschein RL; Caruso V
    Neurobehav Toxicol Teratol; 1982; 4(3):355-64. PubMed ID: 7201569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and dose-dependent decrease of retrograde axonal transport in acrylamide-intoxicated rats.
    Jakobsen J; Sidenius P
    J Neurochem; 1983 Feb; 40(2):447-54. PubMed ID: 6185637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The automated analysis of coordinated hindlimb movement in rats during acute and prolonged exposure to toxic agents.
    Kulig BM; Vanwersch RA; Wolthuis OL
    Toxicol Appl Pharmacol; 1985 Aug; 80(1):1-10. PubMed ID: 4024098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotoxicity testing during long-term studies.
    Ivens I
    Neurotoxicol Teratol; 1990; 12(6):637-41. PubMed ID: 2255308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study on neurotoxicity of acrylamide and glycidamide].
    Deng H; Jiao X; He F
    Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Jul; 31(4):202-5. PubMed ID: 9812576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-dependent acrylamide neurotoxicity in mice: morphology, physiology, and function.
    Ko MH; Chen WP; Lin-Shiau SY; Hsieh ST
    Exp Neurol; 1999 Jul; 158(1):37-46. PubMed ID: 10448416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nervous and vestibular toxicities of acrylonitrile and iminodipropionitrile.
    Llorens J; Soler-Martín C; Cutillas B; Saldaña-Ruíz S
    Toxicol Sci; 2009 Jul; 110(1):244-5; author reply 246-8. PubMed ID: 19403855
    [No Abstract]   [Full Text] [Related]  

  • 19. Low protein diet modifies acrylamide neurotoxicity.
    Khanna VK; Husain R; Seth PK
    Toxicology; 1988 May; 49(2-3):395-401. PubMed ID: 2836975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenterally administered 3-nitropropionic acid and amphetamine can combine to produce damage to terminals and cell bodies in the striatum.
    Bowyer JF; Clausing P; Schmued L; Davies DL; Binienda Z; Newport GD; Scallet AC; Slikker W
    Brain Res; 1996 Mar; 712(2):221-9. PubMed ID: 8814896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.